Xenograft bioprosthetic heart valves: Past, present and future.

The transplantation (implantation) of xenograft heart valves into humans has been carried out for >50 years. There has been considerable research into making this form of xenotransplantation successful, though it is not perfect yet. We review the understanding of the immune response to xenograft heart valves. Important steps in the history include understanding (i) the importance of glutaraldehyde in decreasing the immune response and (ii) the relationship between calcification (which is the main problem leading to xenograft failure) and the immune response. We subsequently discuss the importance of identifying xenoantigens that are important in leading to xenograft valve failure, and the potential of genetically-engineered pigs to allow the development of the 'ideal' heart valve for clinical valve replacement.

[1]  J. Fabiani,et al.  Does glutaraldehyde induce calcification of bioprosthetic tissues? , 1998, The Annals of thoracic surgery.

[2]  P. Gagneux,et al.  Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc , 2014, Immunogenetics.

[3]  G. Gerosa,et al.  First quantification of alpha‐Gal epitope in current glutaraldehyde‐fixed heart valve bioprostheses , 2013, Xenotransplantation.

[4]  F. Fitzal,et al.  Different modes of degeneration in autologous and heterologous heart valve prostheses. , 2000, The Journal of heart valve disease.

[5]  Mingshu Sun,et al.  Exploring the role of short-course cyclosporin a therapy in preventing homograft valve calcification after transplantation. , 2014, Cellular immunology.

[6]  J. Riddle,et al.  Leukocytes, Platelets, and Surface Microstructure of Spontaneously Degenerated Porcine Bioprosthetic Valves , 1988, Journal of cardiac surgery.

[7]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[9]  G L Hallman,et al.  Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients. , 1985, Journal of vascular surgery.

[10]  W. Klepetko,et al.  Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery , 2005, European journal of clinical investigation.

[11]  L Robert,et al.  Biological factors affecting long-term results of valvular heterografts. , 1969, The Journal of thoracic and cardiovascular surgery.

[12]  G. Korbutt,et al.  Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection , 2006, Circulation.

[13]  Jean-Paul Soulillou,et al.  Potential deleterious role of anti‐Neu5Gc antibodies in xenotransplantation , 2015, Xenotransplantation.

[14]  Dan T Simionescu,et al.  Prevention of calcification in bioprosthetic heart valves: challenges and perspectives , 2004, Expert opinion on biological therapy.

[15]  A. Schwell,et al.  Immunogenicity of glutaraldehyde-tanned bovine pericardium. , 1990, The Journal of thoracic and cardiovascular surgery.

[16]  R. Pierson,et al.  Clinical lung xenotransplantation – what donor genetic modifications may be necessary? , 2012, Xenotransplantation.

[17]  D. Cooper.  How important is the anti-Gal antibody response following the implantation of a porcine bioprosthesis? , 2009, The Journal of heart valve disease.

[18]  S. Teneberg,et al.  Characterization of acid and non‐acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts , 2014, Xenotransplantation.

[19]  A. Varki,et al.  Long-Term IgG Response to Porcine Neu5Gc Antigens without Transmission of PERV in Burn Patients Treated with Porcine Skin Xenografts , 2013, The Journal of Immunology.

[20]  Wolfgang Konertz,et al.  Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves. , 2011, Tissue engineering. Part A.

[21]  D. Cooper,et al.  Anti-Gal, alpha-Gal epitopes, and xenotransplantation. , 1999, Sub-cellular biochemistry.

[22]  Yong Jin Kim,et al.  Anti alpha-gal immune response following porcine bioprosthesis implantation in children. , 2010, The Journal of heart valve disease.

[23]  Christopher J. Gregg,et al.  A red meat-derived glycan promotes inflammation and cancer progression , 2014, Proceedings of the National Academy of Sciences.

[24]  C. Burlak,et al.  Double knockout pigs deficient in N‐glycolylneuraminic acid and Galactose α‐1,3‐Galactose reduce the humoral barrier to xenotransplantation , 2013, Xenotransplantation.

[25]  David K C Cooper,et al.  Expression of NeuGc on pig heart valves , 2015, Xenotransplantation.

[26]  J. Butany,et al.  Bioprosthetic heart valves: modes of failure , 2009, Histopathology.

[27]  R. Williams,et al.  Studies of human lymphocytes in the newborn and the aged. , 1975, The American journal of medicine.

[28]  C. Pourcel,et al.  Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Galα1–3Gal), blood group H determinant andN-glycolylneuraminic acid , 1996, Glycoconjugate Journal.

[29]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[30]  A. Menkis,et al.  Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. , 2011, The Journal of thoracic and cardiovascular surgery.

[31]  A. Carpentier,et al.  Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. , 1974, The Journal of thoracic and cardiovascular surgery.

[32]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[33]  Hee-Jin Jeong,et al.  Detection of Hanganutziu–Deicher antigens in O‐glycans from pig heart tissues by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry , 2013, Xenotransplantation.

[34]  C. McGregor,et al.  Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves. , 2013, The Journal of heart valve disease.

[35]  A. Zhu,et al.  Anti‐N‐glycolylneuraminic acid antibodies identified in healthy human serum , 2002, Xenotransplantation.

[36]  Frederick J Schoen,et al.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. , 2005, The Annals of thoracic surgery.

[37]  I. Orme,et al.  Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig. , 2008, Tuberculosis.

[38]  R. Słomski,et al.  Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique , 2015, Journal of Materials Science: Materials in Medicine.

[39]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[40]  Alain Carpentier,et al.  Gal knockout pig pericardium: new source of material for heart valve bioprostheses. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  Yong Jin Kim,et al.  In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse. , 2013, Tissue engineering. Part A.

[42]  L. Liaw,et al.  Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.